326 related articles for article (PubMed ID: 33758518)
21. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
[TBL] [Abstract][Full Text] [Related]
22. High incidence of drug-resistant Mycobacterium tuberculosis in Hainan Island, China.
Lin M; Zhong Y; Chen Z; Lin C; Pei H; Shu W; Pang Y
Trop Med Int Health; 2019 Sep; 24(9):1098-1103. PubMed ID: 31278806
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and factors associated with multidrug-resistant tuberculosis in South India.
Shivekar SS; Kaliaperumal V; Brammacharry U; Sakkaravarthy A; Raj CKV; Alagappan C; Muthaiah M
Sci Rep; 2020 Oct; 10(1):17552. PubMed ID: 33067551
[TBL] [Abstract][Full Text] [Related]
25. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases.
Guenaoui K; Harir N; Ouardi A; Zeggai S; Sellam F; Bekri F; Cherif Touil S
Ann Transl Med; 2016 May; 4(9):168. PubMed ID: 27275481
[TBL] [Abstract][Full Text] [Related]
26. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
van Maaren PJ
Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
[TBL] [Abstract][Full Text] [Related]
27. More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant.
Tesfay K; Tesfay S; Nigus E; Gebreyesus A; Gebreegziabiher D; Adane K
Int J Mycobacteriol; 2016 Sep; 5(3):324-327. PubMed ID: 27847018
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
[TBL] [Abstract][Full Text] [Related]
30. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China.
Liu Z; Zhang M; Wang J; Chen S; Wu B; Zhou L; Pan A; Wang W; Wang X
Biomed Res Int; 2020; 2020():3159482. PubMed ID: 32104686
[TBL] [Abstract][Full Text] [Related]
32. Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
Liu Z; Dong H; Wu B; Zhang M; Zhu Y; Pang Y; Wang X
J Infect; 2019 Oct; 79(4):349-356. PubMed ID: 31400354
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
[TBL] [Abstract][Full Text] [Related]
34. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and characterization of drug-resistant tuberculosis in a local hospital of Northeast China.
Yang Y; Zhou C; Shi L; Meng H; Yan H
Int J Infect Dis; 2014 May; 22():83-6. PubMed ID: 24556164
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
37. A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border.
Becerril-Montes P; Said-Fernández S; Luna-Herrera J; Caballero-Olín G; Enciso-Moreno JA; Martínez-Rodríguez HG; Padilla-Rivas G; Nancy-Garza-Treviño E; Molina-Salinas GM
Mem Inst Oswaldo Cruz; 2013 Apr; 108(2):160-6. PubMed ID: 23579794
[TBL] [Abstract][Full Text] [Related]
38. [Analysis on drug sensitivity spectrum of 167 multidrug-resistant
Chen R; Li MC; Zhao LL; Zhao XQ; Liu HC; Liu ZG; Lu Y; Deng YL; Chen ZX; Wan KL; Yuan XQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):764-769. PubMed ID: 32447922
[No Abstract] [Full Text] [Related]
39. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
